DigIT Pharma Commercial Excellence & Digital Health

September 28-29, 2022 | Germany

DigIT Pharma
Future of Pharma Business: New Pharma Business Unit Opportunities – Datengetriebene Business Itelligence und Commercial Excellence in Zeiten von DIGAs, 

Spotlight

Efficacy issues due to inadequate gastrointestinal (GI) absorption caused by insufficient aqueous solubility are encountered in up to 70% of new drugs in development. 1 Typically, in vitro analysis and preclinical studies are used to predict the behaviour of the drug in vivo.


OTHER PAST CONFERENCES

The Future of Pharmacy

November 11, 2022 | UK

Join us and discover how much pharmacy is changing. It's a day for you to listen, to learn and to discuss - as well as to enjoy meeting all your fellow professionals.

The World’s Leading Extreme Medicine Conference

November 19-21, 2022 | USA

We have brought together the best experts and thought leaders in extreme medicine, covering 14 different themes, to deliver 3 days of world class content.

Pharma Industry & pharmaceuticals

October 3-4, 2022 | France

After a decent assembling of past drug organization gatherings, drug Conferences group merrily invites individuals from everyplace the planet to venture out to " third International meeting on Pharma Industry and drugs"

Pharma 2022

October 11-13, 2022 | France

Comprehensive frameworks for equitable access and accelerated digital transformations are soon to be realized. But progress is slowing, risking a return to the old model plagued by persistent health disparities.

Spotlight

Efficacy issues due to inadequate gastrointestinal (GI) absorption caused by insufficient aqueous solubility are encountered in up to 70% of new drugs in development. 1 Typically, in vitro analysis and preclinical studies are used to predict the behaviour of the drug in vivo.

resources